🟢 Recursion Pharmaceuticals is trading 4.35% up in pre-market as broader markets advance

Recursion Pharmaceuticals is trading at $3.84, up 4.35%, in pre-market, moving in the same direction as a broader market advance.

• The S&P 500 is up 1.04% and the Nasdaq Composite is up 0.96%.
• November 2 results beat revenue and loss-per-share estimates; shares fell 3.92% on November 3, a reaction that does not clearly explain this morning’s rebound.
• Results also reported positive REC-4881 data and cash runway into 2029.